We use cookies to improve site performance and enhance your user experience. If you'd like to disable cookies on this device, please see our cookie management page.
If you close this message or continue to use this site, you consent to our use of cookies on this devise in accordance with our cookie policy, unless you disable them.

Close

Find a share

Search for UK shares

Search

Market movers

United Kingdom
movers are constituents of the FTSE 350.
% GainersCompany
content
IC ViewLastChange
Serco Group PLC
SRP:LSE
127.50
GBX
+9.50
+8.05%
Just Eat PLC
JE.:LSE
437.40
GBX
+30.60
+7.52%
AVEVA Group PLC
AVV:LSE
1,884
GBX
+76.00
+4.20%
Betfair Group PLC
BET:LSE
2,504
GBX
+98.00
+4.07%
easyJet plc
EZJ:LSE
1,605
GBX
+59.00
+3.82%
Bovis Homes Group PLC
BVS:LSE
1,153
GBX
+40.00
+3.59%
ARM Holdings PLC
ARM:LSE
1,074
GBX
+37.00
+3.57%
Redrow PLC
RDW:LSE
458.30
GBX
+15.40
+3.48%
Barratt Developments PLC
BDEV:LSE
635.50
GBX
+21.00
+3.42%
Tui AG
TUI:LSE
1,065
GBX
+35.00
+3.40%
As of Jul 01 2015 13:29 BST.

Companies news

Who bought who
Deal status
Deal value
Date
Willis Group Holdings PLCacquiredTowers Watson & CoAnnounced8.37bn30 Jun 2015
Eckoh PLCacquiredNetcall PLCAnnounced138.07m25 Jun 2015
Emerson Electric CoacquiredSpectronix LtdAnnounced99.00m29 Jun 2015
Tourmaline Oil CorpacquiredMapan Energy LtdAnnounced84.67m29 Jun 2015
First Merchants CorpacquiredAmeriana BancorpAnnounced69.59m29 Jun 2015
1-5 of 12 results

Companies news

Financial Times articles may require a separate login and/or subscription to FT.com

Currency slump dents corporate Indonesia
Sir Howard does the polymath on Heathrow
Housing disparity in tale of two cities
Facebook wins latest case in privacy suit
Greene King sales growth slows

Featured company

Epistem Holdings PLCEHP:LSE

Epistem Holdings Plc (Epistem) is a United Kingdom-based biotechnology company focusing on epithelial stem cells in the areas of oncology, gastrointestinal disease, dermatology and ageing

© Thomson Reuters Click for restrictions.

All markets data located on Investors Chronicle is subject to the Investors Chronicle Terms & Conditions.

All content on Investors Chronicle is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by Investors Chronicle and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Conditions.

Advertiser reports

Register today and get...

Register today and get...
Please note terms & conditions apply